Recombinant multi-species SASH1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SASH1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a scaffold protein involved in the TLR4 signaling pathway that may stimulate cytokine production and endothelial cell migration in response to invading pathogens. The encoded protein has also been described as a potential tumor suppressor that may negatively regulate proliferation, apoptosis, and invasion of cancer cells, and reduced expression of this gene has been observed in multiple human cancers. Mutations in this gene may be associated with abnormal skin pigmentation in human patients. [provided by RefSeq, Oct 2016]
The Alternative Names of target: 1100001C18Rik,2500002E12Rik,A330076K04Rik,CAPOK,DUH,DUH1,Proline-glutamate repeat-containing protein,RGD1566017,SAM and SH3 domain-containing protein 1,SASH1,SH3D6A,Sash1,dJ323M4.1,mKIAA0790
Go
to SASH1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP6834-Ag-1/ GM-Tg-hg-IP6834-Ag-2 | Human SASH1 protein | Human |
| GM-Tg-rg-IP6834-Ag-1/ GM-Tg-rg-IP6834-Ag-2 | Rat SASH1 protein | Rat |
| GM-Tg-mg-IP6834-Ag-1/ GM-Tg-mg-IP6834-Ag-2 | Mouse SASH1 protein | Mouse |
| GM-Tg-cynog-IP6834-Ag-1/ GM-Tg-cynog-IP6834-Ag-2 | Cynomolgus/Rhesus macaque SASH1 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP6834-Ag-1/ GM-Tg-felg-IP6834-Ag-2 | Feline SASH1 protein | Feline |
| GM-Tg-cang-IP6834-Ag-1/ GM-Tg-cang-IP6834-Ag-2 | Canine SASH1 protein | Canine |
| GM-Tg-bovg-IP6834-Ag-1/ GM-Tg-bovg-IP6834-Ag-2 | Bovine SASH1 protein | Bovine |
| GM-Tg-equg-IP6834-Ag-1/ GM-Tg-equg-IP6834-Ag-2 | Equine SASH1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP6834-Ag-1/ GM-Tg-hg-IP6834-Ag-2;
GM-Tg-rg-IP6834-Ag-1/ GM-Tg-rg-IP6834-Ag-2;
GM-Tg-mg-IP6834-Ag-1/ GM-Tg-mg-IP6834-Ag-2; GM-Tg-cynog-IP6834-Ag-1/ GM-Tg-cynog-IP6834-Ag-2; GM-Tg-felg-IP6834-Ag-1/ GM-Tg-felg-IP6834-Ag-2; GM-Tg-cang-IP6834-Ag-1/ GM-Tg-cang-IP6834-Ag-2; GM-Tg-bovg-IP6834-Ag-1/ GM-Tg-bovg-IP6834-Ag-2; GM-Tg-equg-IP6834-Ag-1/ GM-Tg-equg-IP6834-Ag-2 |
| Products Name | SASH1 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | SASH1 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SASH1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.